Source: Quantib Blog

Quantib Blog Dr. Steiner’s real-world validation study of Quantib® Prostate

Scientific reviews | 4 Title: AI Enabled Diagnosis of Prostate Cancer with Multiparametric 3T imaging. Hands on preliminary evaluation: QuantibAuthor: Edward Steiner, MD Publication: RSNA, November 2022

Read full article »

Quantib's Competitors | Quantib's News | Quantib's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Arthur Post Uiterweer

CEO Approval Rating

50/100

Quantib is a Netherlands-based AI and machine learning company that offers solutions including clinical and medical imaging for prostate cancer and neurodegeneration.